Search Results

Nicole (Nicki) Perry-Hauser is now available What a fun chat! 📹Would you like to see the video?

Stuart Maudsley, Nicole Perry-Hauser, Lauren Slosky, Cesare Orlandi, and Simone Prömel. Terry Kenakin's "Applying Pharmacology to Drug Discovery" course at Dr.

Nicole Perry-Hauser, on her selection as a 2024 Discovery Science Emerging Scholar at Vanderbilt University Terry Kenakin. The course covers basic pharmacology in four weekly segments.

Welcome Back, Discovery Drivers   Terry’s Corner is live, on-demand pharmacology built for drug discovery Dr.GPCR Updates Terry’s Corner is Live - Pharmacology at your fingertips Terry’s Corner is now open! Terry Kenakin with short videos, clear summaries, and curated references. Want the full breakdown and your discount code for Terry's Corner? Better pharmacology leads to better decisions—unlock it now with Terry’s Corner.

Hello GPCR Innovators ,   We’re preparing to launch Terry’s Corner, a new knowledge hub shaped by Dr. Terry Kenakin’s decades of GPCR insight. ST171, a biased 5‑HT1A agonist, delivers selective pain relief in preclinical models Dr.GPCR Updates Terry Terry’s Corner gives you timeless and timely tools to improve selectivity, model efficacy, and design

November 2021 Read more at the source #DrGPCR #GPCR #IndustryNews

Hello GPCR Minds,   This week, you'll learn all about Terry’s Pharmacology Corner, your new learning Terry Kenakin   Terry’s Corner is your space focused on GPCR pharmacology designed just for you.   Terry Kenakin brings translational clarity to complex receptor concepts.  

In this podcast episode , Alessandro Nicoli shares how becoming the first PhD student in a new lab shaped —Alessandro Nicoli Delegating Is a Process Learning to delegate was not easy. —Alessandro Nicoli He discovered that investing time in people pays off. —Alessandro Nicoli This two-way growth has turned mentoring into one of his favorite parts of PhD life

Alessandro Nicoli’s wasn’t. —Alessandro Nicoli This perspective changed everything. —Alessandro Nicoli After graduation, a serendipitous email from Prof. Explore the   GPCR University  or enroll in Terry's Corner for GPCR Courses led by Dr. Terry Kenakin. ________ Keyword Cloud: #GPCRresearch #DrugDiscovery #ComputationalChemistry #MolecularModeling

One of its first pillars, Terry’s Pharmacology Corner , led by Dr. Terry Kenakin , continues to grow. Through Terry’s Pharmacology Corner , he shares decades of expertise in an accessible, on-demand format Terry Kenakin , a pioneer who helped shape modern pharmacology and deepen our understanding of GPCR function Related Links 🔗 Explore Terry’s Pharmacology Corner → TerryKenakin.com 📧 Connect with us →   Hello@

Today, we're thrilled to announce that Terry's Corner is officially live !   What's inside Terry's Corner?   GPCR Premium Members a significantly reduced access  to Terry's Corner for a limited time.   Explore Terry's Corner Better decisions start with better pharmacology. GPCR Team & Terry’s Desk

In the foundational lesson of Terry’s Corner , Dr. Terry Kenakin invites us to challenge outdated assumptions and step into a new era of drug discovery. Now, Terry is opening the vault. This isn’t theory. Join Terry’s Corner and stay updated on the latest in GPCR research—delivered in a format that’s as approachable Unlock "Why Terry's Corner" now

Terry’s Corner is coming soon. Dr. GPCR Updates Terry’s Corner Is Coming – Get Early Access and Updates    Terry’s Corner is launching Terry Kenakin. Explore Terry's Corner From Chemistry Lab to GPCR Partner – New Podcast with Celtarys Dr. Terry’s Corner is coming soon. Stay curious, The Dr. GPCR Team

Pharmacology Research Associate - Professor Graeme Milligan Postdoc in Molecular Pharmacology - The Hauser

Nicola Smith, Molecular Pharmacologist, lab head, and senior lecturer at UNSW Sydney.

That’s exactly what Terry’s Corner delivers this week: high-impact insight into GPCR allostery, crafted Terry's Corner : Stop Chasing Affinity and Start Reading the System In this week’s cornerstone Terry’ Terry Kenakin reframes GPCRs as dynamic, allosteric sensors—far from static binding sites. Terry Kenakin on “The Kinetics of Allostery: The Added Benefits of Allosteric Function.”

Kenakin from Terry's Corner shows how to tame irreversible drugs so their kinetic power works for you Terry's Corner – Control Target Engagement—Don’t Chase It with Irreversible Drugs When binding outlives Kenakin Trusted insights from biotech, pharma, and academia 🎬 Plus New: Lesson Trailers   Curious about Terry

I’m honored to be chairing a session  in this track — with none other than Terry Kenakin  on the speaker Takeda   🎥 Interview with Kris Borzilleri & Alison Heick Varghese from Pfizer 🎥 Interview with Terry Kenakin from UNC and Terry's Corner We'll continue to update this section as new videos are released   📚 Terry’s Corner — The Only On-Demand Pharmacology Hub with Dr. For those who can’t get enough of Terry’s insights at Discovery on Target, Terry’s Corner  keeps the

Receptor Theory, Biased Signaling & Assay Interpretation The first GPCR Pharmacology AMA of 2026  at Terry Terry’s Corner Expands to YouTube Terry’s Corner is now on YouTube. Access the white paper here Why Terry’s Pharmacology Corner Mechanistic understanding evolves. Terry’s Pharmacology Corner provides a structured environment to maintain interpretive discipline: Weekly AMAs, and quantitative pharmacology deep dives: 👉 Access Terry’s Corner Free for 7 Days Strengthen

That’s exactly what Terry’s Corner delivers this week: a deep dive into molecular creativity, rational Terry’s Corner: Why Chemistry Still Rules For decades, discovery focused on targets. Terry Kenakin reveals how drug chemistry defines function, not just fit. Learn what’s next. 🟢 Premium Members get 50%+ discount when they join Terry’s Corner. 👉 Access this

That’s exactly what Terry’s Corner delivers every week: practical tools from Dr. Terry Kenakin to elevate your science and sharpen your decisions. Terry's Corner : Unlock the Power of Intracellular GPCR Drugs For years, GPCR drug discovery has focused Terry Kenakin delivers a game-changing framework for teams grappling with the gap between in vitro potency GPCR Podcast, we sit down with Alessandro Nicoli, from the Technical University of Munich, to discuss

For Alessandro Nicoli, it’s an opportunity. —Alessandro Nicoli For the first time, researchers had a reliable set of predicted structures to work —Alessandro Nicoli A New Era of GPCR Research AlphaFold didn’t just fill a gap—it shifted the focus of —Alessandro Nicoli The result?

kinases, emphasizing their role as hubs for increasing local effector concentrations near active GPCRs (Perry-Hauser

Hassan , Umut Onur Özcan ,   Jimmy Caroli ,   Albert J Kooistra ,   David E Gloriam ,   Alexander S Hauser A bitter anti-inflammatory drug binds at two distinct sites of a human bitter taste GPCR Lior Peri ,   Pharmacology Research Associate - Professor Graeme Milligan Postdoc in Molecular Pharmacology - The Hauser

Terry Kenakin's educational initiative this fall! Pharmacology Research Associate - Professor Graeme Milligan Postdoc in Molecular Pharmacology - The Hauser

as one of the most tractable classes of drug targets and are targeted by 30%–40% of current drugs (Hauser

studies have also reported GPR84 involvement in pain, atherosclerosis, and even metabolic disorders (Nicol

Alessandro Berghella , Brinda K Rana , G Enrico Rovati , Valerie Capra , Caroline M Gorvin , Alexander S Hauser Pharmacology Research Associate - Professor Graeme Milligan Postdoc in Molecular Pharmacology - The Hauser

This week's highlight includes congrats to: Miles Thompson , Alexander Hauser , Caroline Gorvin ,   et Terry Kenakin with our premium membership and enjoy a 1-month FREE trial! Terry Kenakin Reading Materials Access to the private group Certificate of participation Learn the essentials

Terry Kenakin's educational initiative this fall! Pharmacology Research Associate - Professor Graeme Milligan Postdoc in Molecular Pharmacology - The Hauser